Virtu KCG Holdings’s Pfizer PFE Stock Holding History

Virtu KCG Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-80,420	Closed	-$2.46M	–	3457
2015 Q4	$2.46M	Buy	80,420 +16,126	+25%	+$507K	0.04%	327
2015 Q3	$1.92M	Buy	64,294 +14,651	+30%	+$470K	0.03%	476
2015 Q2	$1.58M	Buy	49,643 +12,015	+32%	+$392K	0.03%	548
2015 Q1	$1.24M	Sell	37,628 -15,494	-29%	-$493K	0.03%	618
2014 Q4	$1.57M	Sell	53,122 -39,841	-43%	-$1.14M	0.03%	578
2014 Q3	$2.61M	Sell	92,963 -109,721	-54%	-$3.08M	0.05%	333
2014 Q2	$5.71M	Sell	202,684 -180,550	-47%	-$5.15M	0.09%	146
2014 Q1	$11.7M	Buy	383,234 +115,729	+43%	+$3.45M	0.15%	87
2013 Q4	$7.77M	Buy	267,505 +214,910	+409%	+$6.25M	0.09%	127
2013 Q3	$1.43M	Buy	+52,595	New	+$1.43M	0.02%	859

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's PFE Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Pfizer (PFE) stake by 77% in Q2 2017, selling an estimated $1.83M and leaving 17,567 shares worth $560K. The position accounts for 0.02% of the portfolio, ranked #1044.

Virtu KCG Holdings first reported a position in PFE in Q3 2013 and has held it in 16 quarters since. The position peaked at $5.54M in Q4 2013. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Virtu KCG Holdings held 17,567 shares of Pfizer worth $560K as of Q2 2017.
Virtu KCG Holdings sold 57,880 Pfizer shares in Q2 2017, an estimated $1.83M.
Pfizer made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #1044 holding.
Virtu KCG Holdings first reported a position in Pfizer in Q3 2013 and has held it in 16 quarters since.
Virtu KCG Holdings's Pfizer position peaked at $5.54M in Q4 2013.
2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.